Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-19-021318
Filing Date
2019-06-03
Accepted
2019-05-31 19:00:16
Documents
79
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 6-K meso-6k_20190331.htm 6-K 5018471
  Complete submission text file 0001564590-19-021318.txt   17685206

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT meso-20190331.xml EX-101.INS 5155957
3 XBRL TAXONOMY EXTENSION SCHEMA meso-20190331.xsd EX-101.SCH 94212
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meso-20190331_cal.xml EX-101.CAL 86694
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meso-20190331_def.xml EX-101.DEF 230888
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE meso-20190331_lab.xml EX-101.LAB 525762
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meso-20190331_pre.xml EX-101.PRE 411833
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 19871813
SIC: 2836 Biological Products, (No Diagnostic Substances)